Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Meiwu Technology | WNW | Dec 26, 2024 | 1.74 | -20.55 |
Melar Acquisition I | MACI | Dec 26, 2024 | 10.06 | 0.00 |
Melar Acquisition I | MACIU | Dec 26, 2024 | 10.12 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Dec 26, 2024 | 5.92 | -1.00 |
MercadoLibre | MELI | Dec 26, 2024 | 1 732.76 | -0.60 |
Mercantile Bank | MBWM | Dec 26, 2024 | 45.56 | +0.37 |
Mercer International | MERC | Dec 26, 2024 | 6.58 | -3.52 |
Merchants Bancorp | MBIN | Dec 26, 2024 | 36.94 | +1.68 |
Merchants Bancorp B | MBINO | Dec 26, 2024 | 24.96 | 0.00 |
Merchants Bancorp C Pref | MBINN | Dec 26, 2024 | 20.72 | +0.10 |
Merchants Bancorp Pref D | MBINM | Dec 26, 2024 | 26.23 | +0.48 |
Merck & Co | MRK | Dec 26, 2024 | 99.87 | +0.42 |
Mercurity Fintech | MFH | Dec 26, 2024 | 5.82 | -5.06 |
Mercury General | MCY | Dec 26, 2024 | 68.58 | -0.38 |
Mercury Systems | MRCY | Dec 26, 2024 | 41.99 | +3.22 |
Mereo BioPharma ADR | MREO | Dec 26, 2024 | 3.77 | -1.05 |
Meridian | MRBK | Dec 26, 2024 | 13.84 | -1.11 |
MeridianLink | MLNK | Dec 26, 2024 | 21.44 | +0.37 |
Merit Medical Systems | MMSI | Dec 26, 2024 | 98.44 | +0.37 |
Meritage Homes | MTH | Dec 26, 2024 | 156.10 | 0.00 |
Merrill Lynch & Co. | IPB | Dec 26, 2024 | 25.51 | +0.28 |
Mersana Therapeutics | MRSN | Dec 26, 2024 | 1.42 | -12.35 |
Merus N.V | MRUS | Dec 26, 2024 | 43.10 | +1.63 |
Mesa Air Group | MESA | Dec 26, 2024 | 1.33 | +16.23 |
Mesa Laboratories | MLAB | Dec 26, 2024 | 135.62 | +3.33 |
Mesa Royalty Trust | MTR | Dec 26, 2024 | 6.17 | +1.90 |
Mesabi Royalty Trust | MSB | Dec 26, 2024 | 28.60 | +0.85 |
Mesoblast ADR | MESO | Dec 26, 2024 | 18.29 | +7.46 |
Meta Materials | MMAT | Dec 26, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Dec 26, 2024 | 603.35 | -0.72 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.